Atlas Trials

COVID-19 Antibody Responses In Cystic Fibrosis

Clinical trial NCT06274840 · RECRUITING

Trial details

NCT number
NCT06274840
Sponsor
Pilar Azevedo
Status
RECRUITING
Study type
OBSERVATIONAL
COVID-19Cystic Fibrosis
Start date
2022-08-08
Primary completion
2025-09-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.